Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Dallah Healthcare CoSAU:4004 90 Receivables Turnover is 0.80 as of Jun. 2026. GuruFocus rates SAU:4004 with a GF Score™ of 90/100 and a GF Value™ of ﷼196.96 (Significantly Undervalued). The stock has 6 warning signs investors should review. Among 659 Healthcare Providers & Services companies, Dallah Healthcare Co ranks worse than 84.52% on this metric.
The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Dallah Healthcare Co's Revenue for the
three
months ended in Jun. 2026 was ﷼1,108 Mil. Dallah Healthcare Co's average Accounts Receivable for the
three
months ended in Jun. 2026 was ﷼1,393 Mil.
Hence, Dallah Healthcare Co's Receivables Turnover for the
three
months ended in Jun. 2026 was 0.80.
Dallah Healthcare Co (SAU:4004) Receivables Turnover Explanation
An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.
Dallah Healthcare Co Receivables Turnover Related Terms
Dallah Healthcare Co Receivables Turnover Historical Data
* Premium members only.
The historical data trend for Dallah Healthcare Co's Receivables Turnover can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SAU:4004 vs HCA, THC, DVA: Receivables Turnover Comparison
For the Medical Care Facilities subindustry, Dallah Healthcare Co's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Dallah Healthcare Co Receivables Turnover vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Dallah Healthcare Co's Receivables Turnover distribution charts can be found below:
* The bar in red indicates where Dallah Healthcare Co's Receivables Turnover falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Dallah Healthcare Co (SAU:4004) has a Receivables Turnover of 0.80 as of Jun. 2026. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Dallah Healthcare Co and its competitors. According to the industry distribution chart, Dallah Healthcare Co ranks #557 out of 659 companies in the Healthcare Providers & Services industry, placing it in the top 84.5%.
Is Dallah Healthcare Co's Receivables Turnover too high?
Dallah Healthcare Co's current Receivables Turnover is 0.80. The Healthcare Providers & Services industry median Receivables Turnover is 7.96. Dallah Healthcare Co's value of 0.80 is 89.9% below this industry median. Based on the distribution chart, Dallah Healthcare Co ranks #557 out of 659 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Dallah Healthcare Co has a GF Score™ of 90/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Dallah Healthcare Co's Receivables Turnover compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Dallah Healthcare Co ranks #557 out of 659 companies for Receivables Turnover. This places Dallah Healthcare Co in the lower half of its industry. The industry median Receivables Turnover is 7.96. Dallah Healthcare Co's value of 0.80 is 89.9% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Receivables Turnover for a Healthcare Providers & Services company?
The median Receivables Turnover among Healthcare Providers & Services companies is 7.96, based on 659 companies in the industry. Companies in the top quartile (top 25%) have a Receivables Turnover significantly above this median, while those in the bottom quartile fall well below. However, Receivables Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Dallah Healthcare Co's current Receivables Turnover of 0.80 is 89.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Receivables Turnover mean?
A high Receivables Turnover can signal that a stock is expensive relative to its fundamentals. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Dallah Healthcare Co and its competitors. For the Healthcare Providers & Services industry, the median Receivables Turnover is 7.96 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Dallah Healthcare Co's current Receivables Turnover is 0.80. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dallah Healthcare Co stock overvalued right now?
Based on GuruFocus' analysis, Dallah Healthcare Co (SAU:4004) is currently considered Significantly Undervalued. The stock's GF Value™ is ﷼196.96, compared to a current price of ﷼97.05 — trading 50.7% below its estimated fair value. The current Receivables Turnover is 0.80 and 89.9% below the Healthcare Providers & Services industry median of 7.96. Dallah Healthcare Co's overall GF Score™ is 90/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Receivables Turnover calculated?
Receivables Turnover is calculated from a company's financial statements. For Dallah Healthcare Co (SAU:4004), the current Receivables Turnover is 0.80 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Dallah Healthcare Co (SAU:4004) Overvalued in 2026?
Based on GuruFocus' analysis, Dallah Healthcare Co stock appears to be undervalued.
The current stock price of ﷼97.05 is trading 50.7% below its estimated GF Value™ of ﷼196.96.
GuruFocus considers Dallah Healthcare Co to be Significantly Undervalued.
Key valuation signals for SAU:4004:
Receivables Turnover: 0.80
GF Value™: ﷼196.96 vs. price of ﷼97.05 (50.7% below fair value)
Industry Position: 89.9% below the Healthcare Providers & Services median (#557 of 659)
No single metric tells the full story. See the SAU:4004 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Dallah Healthcare Co provides and operates healthcare programs and utilities in the Kingdom of Saudi Arabia. The objectives of the company include operating, managing, and maintaining the healthcare entities, wholesale medicines, and retail of medical and surgical equipment, prosthetics, and devices for the disabled, hospital equipment, and manufacturing medicines, pharmaceuticals, herbals, health, cosmetics, detergents, disinfectants, and packaging in the Kingdom of Saudi Arabia. The reportable segments of the company are Medical Facilities and Pharmacies, and Distribution of Pharmaceutical Products. The company generates the majority of its revenue from the Medical Facilities and Pharmacies segment.
90GF Score
Get the complete analysis for SAU:4004
Receivables Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SAU:4004 has been successfully added to your 
